Direction affects distribution of MSS

Article

The membranes found on the retinal surface can cause visual symptoms in various conditions and a patient's vision can often be improved with surgical removal of these membranes, according to Mr Mahmut Dogramaci (The Lister Surgicentre, Lister Hospital, Stevenage, UK).

"Changing the direction at which the epiretinal membrane edge is pulled significantly affects the distribution of maximum shear stress (MSS) in the model," said Mr Mahmut Dogramaci (The Lister Surgicentre, Lister Hospital, Stevenage, UK) when he discussed the results of his studying examining the dynamics of epiretinal membrane removal off the retinal surface using a computer simulation.1

In explaining the reasoning behind the study, Mr Dogramaci stated that the membranes found on the retinal surface can cause visual symptoms in various conditions and a patient's vision can often be improved with surgical removal of these membranes.2–5 "However, very little is published about the optimum direction at which the edge of the membrane should be pulled to assist safe and effective removal," he added.

Dynamics analysis

"We identified the value and the distribution of the maximum shear stress (MSS) in the model during the membrane removal manoeuver," said Mr Dogramaci. The MSS can be used to determine the likelihood of extracellular materials failing (tearing). "We also studied its relation to the direction at which the edge of the membrane is pulled," he added.

The results of the study demonstrated that the direction at which the epiretinal membrane edge is pulled affects the distribution of the MSS and Mr Dogramaci explained that the direction was quantified by the displacement angle (DA) values in degrees. The study showed that changing the pulling direction to about 165° DA allowed the MSS to be redistributed within the tissue complex, making the removal safer and more effective. The study also showed that mean MSS value was significantly higher at the attachment pegs at all directions of pulling, proving the attachment pegs to be the most likely site of tear.

Limitations and further studies

"Computer models are widely used in engineering, less commonly used in medical and surgical, this is mainly due to the difficulties in using and understanding the basics of simulations," stated Mr Dogramaci. He explained that these limitations and difficulties could be overcome through the development of more user-friendly software that includes more biological material property data. "Further studies are now being performed to use reverse engineering techniques to find explanations for some unwanted surgical outcomes after retinal surgeries, for example, unintentional retinal shifts after retinal detachment repair," he added.

Mr Dogramaci concluded, "In reality, experienced surgeons know that changing the direction, at which the epiretinal membrane edge is pulled, significantly affects the distribution of the MSS in the surgical field and they continuously change the direction of the displacement vector as the attachment pegs give away to obtain the optimum result. Experienced surgeons learn this through self intuition. This study enabled us to explain the theory and hence facilitates teaching and learning."

References

1. M. Dogramaci and T.H. Williamson, Br. J. Ophthalmol., Published Online First 11 July 2013, doi: 10.1136/bjophthalmol-2013-303598.

2. Y.N. Hui et al., Arch. Ophthalmol., 1988;106:1280–1285.

3. R.G. Michels, Ophthalmology, 1984;91:1384–1388.

4. M.T. Trese, D.B. Chandler and R. Machemer, Graefes Arch. Clin. Exp. Ophthalmol., 1983;221:12–15.

5. S.M. Ghazi-Nouri et al., Br. J. Ophthalmol., 2006;90:559–562.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Related Content
© 2025 MJH Life Sciences

All rights reserved.